Effects of one-year treatment with canagliflozin or sitagliptin on glycaemic control and beta cell function measures in subjects with type 2 diabetes on metformin plus sulfonylurea

被引：0
|
作者：
Schernthaner, G. [1 ]
Ferrannini, E. [2 ]
Mari, A. [3 ]
Tong, C. [4 ]
Kawaguchi, M. [4 ]
Meininger, G. [4 ]
Polidori, D. [4 ]
机构：
[1] Rudolfstiftung Hosp Vienna, Vienna, Austria
[2] Univ Pisa, Sch Med, I-56100 Pisa, Italy
[3] CNR, Inst Biomed Engn, Padua, Italy
[4] Janssen R&D LLC, Raritan, NJ USA
来源：
DIABETOLOGIA | 2013年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
993
引用
收藏
页码：S398 / S399
页数：2
相关论文
共 50 条
  • [21] COST-EFFECTIVENESS OF CANAGLIFLOZIN (CANA) VERSUS SITAGLIPTIN (SITA) AS ADD-ON TO METFORMIN PLUS SULFONYLUREA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) IN BRAZIL
    Pititto, L.
    Neslusan, C.
    Teschemaker, A. R.
    Johansen, P.
    Willis, M.
    Asano, E.
    Puig, A.
    VALUE IN HEALTH, 2015, 18 (07) : A864 - A864
  • [22] Substantial improvement in β-cell function with initial combination therapy of sitagliptin and metformin in patients with type 2 diabetes after 1 year of treatment
    Williams-Herman, Debora
    Xu, Lei
    Davies, Michael J.
    Stein, Peter P.
    Amatruda, John M.
    DIABETES, 2008, 57 : A161 - A161
  • [23] Exenatide plus metformin and glibenclamide compared with metformin plus glibenclamide on beta cell and alpha cell function and adipocytokines in patients with type 2 diabetes
    Koteshkova, O.
    Antsiferov, M.
    DIABETOLOGIA, 2016, 59 : S378 - S378
  • [24] Effects of Treatment with Metformin and/or Sitagliptin on Beta-Cell Function and Insulin Resistance in Prediabetic Women with Previous Gestational Diabetes
    Barone, Sara
    Dardano, Angela
    Tura, Andrea
    Kurumthodathu, Jancy J.
    Bertolotto, Alessandra
    Bianchi, Cristina
    Giusti, Laura
    Lacaria, Emilia
    Romano, Matilde
    Miccoli, Roberto
    Penno, Giuseppe
    Del Prato, Stefano
    Daniele, Giuseppe
    DIABETES, 2019, 68
  • [25] One-year exenatide treatment improves beta cell response in metformin treated patients with type 2 diabetes which is sustained after 5 weeks discontinuation of treatment
    Bunck, M. C.
    Mari, A.
    Corner, A.
    Eliasson, B.
    Shaginian, R. M.
    Wu, Y.
    Yan, P.
    Heine, R. J.
    Smith, U.
    Taskinen, M. -R.
    Yki-Jarvinen, H.
    Diamant, M.
    DIABETOLOGIA, 2009, 52 : S7 - S7
  • [26] Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and β-cell function in patients with type 2 diabetes
    Brazg, R.
    Xu, L.
    Dalla Man, C.
    Cobelli, C.
    Thomas, K.
    Stein, P. P.
    DIABETES OBESITY & METABOLISM, 2007, 9 (02): : 186 - 193
  • [27] Effects of treatment with metformin and/or sitagliptin on beta-cell function and insulin resistance in prediabetic women with previous gestational diabetes
    Daniele, Giuseppe
    Tura, Andrea
    Dardano, Angela
    Bertolotto, Alessandra
    Bianchi, Cristina
    Giusti, Laura
    Kurumthodathu, Jancy Joseph
    Del Prato, Stefano
    DIABETES OBESITY & METABOLISM, 2020, 22 (04): : 648 - 657
  • [28] Determinants of beta cell function and insulin sensitivity one year from randomised allocation to diet, sulfonylurea or metformin monotherapy in UYPDS patients with newly diagnosed type 2 diabetes
    Holman, R
    Czupryniak, L
    Stratton, IM
    DIABETES, 2005, 54 : A147 - A147
  • [29] Canagliflozin compared with sitagliptin for patients with type 2 diabetes who do not have adequate glycemic control with metformin plus sulfonylurea: a 52-week randomized trial (vol 36, pg 2508, 2013)
    Schernthaner, G.
    DIABETES CARE, 2013, 36 (12) : 4172 - 4172
  • [30] Beta cell function and glycaemic control following one year exenatide therapy, and after 12 week wash-out, in patients with type 2 diabetes
    Corner, A.
    Bunck, M. C.
    Diamant, M.
    Eliasson, B.
    Malloy, J. L.
    Shaginian, R. M.
    Deng, W.
    Kendall, D. M.
    Taskinen, M. R.
    Smith, U.
    Yki-Jarvinen, H.
    Heine, R. J.
    DIABETOLOGIA, 2008, 51 : S351 - S351
12345